Trial Profile
Compassionate Use Program With Lacosamide in Patients With Partial-onset or Generalized Tonic-clonic Seizures ≥16 Years of Age Coming From the SP0994 Study
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 04 Feb 2021
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary)
- Indications Partial epilepsies; Tonic-clonic epilepsy
- Focus Expanded access; Therapeutic Use
- Sponsors UCB Biopharma
- 29 Oct 2019 Status changed from recruiting to completed.
- 26 Jun 2018 New trial record